Kaneka Corporation
4118.T · Tokyo Stock Exchange · JPY
6.158,00JPY
+16,00 (+0,26 %)Stand 10. Nov., 2:30
Kennzahlen
- Eröffnung
- 6.217,00
- Vortag
- 6.142,00
- Tagesspanne
- 6.123,00 – 6.224,00
- 52 Wochen
- 4.113,00 – 6.570,00
- Volumen
- 78.600
- Ø Volumen
- 232.224
- Börsenwert
- 370,36 Mrd. ¥
- KGV
- 10,6
- Gewinn je Aktie (TTM)
- 579,84
- Dividendenrendite
- 3,0 %
- Beta
- 0,3
- Nächste Zahlen
- 11. Nov. 2026
Finanzen
| JPY | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Umsatz | 811,64 Mrd. | 807,2 Mrd. | 762,3 Mrd. | 755,82 Mrd. | 691,53 Mrd. |
| Herstellungskosten | 587,35 Mrd. | 590,98 Mrd. | 567,1 Mrd. | 565,35 Mrd. | 501,1 Mrd. |
| Bruttogewinn | 224,29 Mrd. | 216,23 Mrd. | 195,2 Mrd. | 190,47 Mrd. | 190,43 Mrd. |
| Forschung und Entwicklung | 0 | 39,34 Mrd. | 35,4 Mrd. | 32,67 Mrd. | 30,89 Mrd. |
| Vertrieb und Verwaltung | 192,66 Mrd. | 137,85 Mrd. | 128,4 Mrd. | 123,86 Mrd. | 115,97 Mrd. |
| Operatives Ergebnis | 31,64 Mrd. | 39,04 Mrd. | 31,41 Mrd. | 33,94 Mrd. | 43,56 Mrd. |
| EBITDA | 96,28 Mrd. | 85,46 Mrd. | 81,62 Mrd. | 74,44 Mrd. | 75,98 Mrd. |
| Nettogewinn | 30,98 Mrd. | 25,31 Mrd. | 23,22 Mrd. | 23,01 Mrd. | 26,49 Mrd. |
| Gewinn je Aktie (verwässert) | 499,47 | 399,66 | 356,87 | 348,66 | 404,96 |
Bewertung
Letzte 12 Monate
- KGV
- 10,6
- Kurs-Umsatz-Verhältnis
- 0,4
- Kurs-Buchwert-Verhältnis
- 0,7
- PEG
- 0,2
- Bruttomarge
- 28,2 %
- Operative Marge
- 4,6 %
- Nettomarge
- 4,3 %
- Verschuldungsgrad
- 0,4
- EV/EBITDA
- 5,2
- Eigenkapitalrendite
- 7,3 %
- Kapitalrendite (ROIC)
- 3,4 %
- Free-Cashflow-Rendite
- 0,0 %
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | |
|---|---|---|---|---|---|
| Bruttomarge | 27,6 % | 26,8 % | 25,6 % | 25,2 % | 27,5 % |
| Operative Marge | 3,9 % | 4,8 % | 4,1 % | 4,5 % | 6,3 % |
| Nettomarge | 3,8 % | 3,1 % | 3,0 % | 3,0 % | 3,8 % |
| KGV | 9,6 | 9,5 | 10,6 | 9,9 | 8,7 |
| Kurs-Umsatz-Verhältnis | 0,4 | 0,3 | 0,3 | 0,3 | 0,3 |
| Kurs-Buchwert-Verhältnis | 0,6 | 0,5 | 0,5 | 0,5 | 0,6 |
| Verschuldungsgrad | 0,5 | 0,5 | 0,4 | 0,4 | 0,3 |
| Liquidität 3. Grades | 1,5 | 1,5 | 1,5 | 1,5 | 1,5 |
| Dividendenrendite | 3,1 % | 3,0 % | 2,9 % | 3,3 % | 2,8 % |
| Unternehmenswert | 476,67 Mrd. | 417,81 Mrd. | 397,51 Mrd. | 361,23 Mrd. | 322,37 Mrd. |
| EV/EBITDA | 5,0 | 4,9 | 4,9 | 4,9 | 4,2 |
| Eigenkapitalrendite | 6,2 % | 5,4 % | 5,1 % | 5,5 % | 6,8 % |
| Kapitalrendite (ROIC) | 2,9 % | 3,8 % | 3,0 % | 3,9 % | 5,7 % |
| Free-Cashflow-Rendite | 0,5 % | −4,1 % | 0,2 % | −4,8 % | −1,4 % |
Wachstum
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | |
|---|---|---|---|---|---|
| Umsatz | +0,5 % | +5,9 % | +0,9 % | +9,3 % | +19,8 % |
| Bruttogewinn | +3,7 % | +10,8 % | +2,5 % | +0,0 % | +18,3 % |
| Operatives Ergebnis | −19,0 % | +24,3 % | −7,5 % | −22,1 % | +58,2 % |
| Nettogewinn | +22,4 % | +9,0 % | +0,9 % | −13,1 % | +67,3 % |
| Gewinn je Aktie | +25,0 % | +12,0 % | +2,4 % | −13,9 % | +67,2 % |
| Freier Cashflow | +113,6 % | −1.766,3 % | +105,5 % | −238,8 % | −109,3 % |
| Dividende je Aktie | +30,4 % | +5,1 % | −4,7 % | +15,5 % | −0,0 % |
Analysten
Einstufungen
Gerade nicht verfügbar.
Kursziel
Gerade nicht verfügbar.
Schätzungen
| FY 2027 | FY 2028 | FY 2029 | |
|---|---|---|---|
| Umsatz (Ø) | 875,08 Mrd. | 899,95 Mrd. | 916,5 Mrd. |
| Umsatz (Tief – Hoch) | 836,76 Mrd. – 918,95 Mrd. | 858,56 Mrd. – 944,13 Mrd. | 867 Mrd. – 946 Mrd. |
| Gewinn je Aktie (Ø) | 517,35 | 515,86 | 564,96 |
| Gewinn je Aktie (Tief – Hoch) | 453,66 – 595,51 | 433,02 – 589,61 | 521,07 – 587,00 |
| Analysten | 6 | 5 | 3 |
Quartalszahlen
Nächste Zahlen: 11. Nov. 2026| Aug. 2026 | Mai 2026 | Feb. 2026 | Nov. 2025 | Aug. 2025 | Mai 2025 | Feb. 2025 | Nov. 2024 | |
|---|---|---|---|---|---|---|---|---|
| Gewinn je Aktie · Erwartet | – | – | – | – | – | – | – | – |
| Gewinn je Aktie · Tatsächlich | 148,45 | 204,54 | 120,21 | 108,77 | 67,74 | 120,24 | 120,19 | 49,73 |
| Abweichung | – | – | – | – | – | – | – | – |
| Umsatz · Tatsächlich | 223,03 Mrd. | 213,36 Mrd. | 200,85 Mrd. | 198,75 Mrd. | 198,68 Mrd. | 204,15 Mrd. | 207,09 Mrd. | 197,58 Mrd. |
Dividenden und Splits
| Ex-Tag | Zahltag | Betrag |
|---|---|---|
| 30. März 2027 | 30. März 2027 | 105,00 |
| 29. Sept. 2026 | 29. Sept. 2026 | 105,00 |
| 30. März 2026 | 5. Juni 2026 | 80,00 |
| 29. Sept. 2025 | 5. Dez. 2025 | 80,00 |
| 28. März 2025 | 6. Juni 2025 | 70,00 |
| 27. Sept. 2024 | 5. Dez. 2024 | 60,00 |
| 28. März 2024 | 6. Juni 2024 | 55,00 |
| 28. Sept. 2023 | 5. Dez. 2023 | 55,00 |
| 30. März 2023 | 12. Juni 2023 | 55,00 |
| 29. Sept. 2022 | 5. Dez. 2022 | 55,00 |
| 30. März 2022 | 13. Juni 2022 | 60,00 |
| 29. Sept. 2021 | 6. Dez. 2021 | 50,00 |
Aktiensplits
- 26. Sept. 20181:5
Eigentümer
Institutionen
Gerade nicht verfügbar.
Insider-Geschäfte
–
Vergleichbare Unternehmen
4005.TSumitomo Chemical Company, Limited503,60+4,27 %
4023.TKureha Corporation4.315,00+0,94 %
4182.TMitsubishi Gas Chemical Company, Inc.3.306,00+5,05 %
4202.TDaicel Corporation1.620,00+1,57 %
4203.TSumitomo Bakelite Company Limited7.168,00+9,39 %
4205.TZeon Corporation2.059,00+2,72 %
4208.TUBE Corporation3.260,00+1,65 %
4401.TAdeka Corporation4.298,00+4,04 %
Über das Unternehmen
Kaneka Corporation, established in Tokyo, Japan, in 1949, operates internationally as a diversified manufacturer providing a wide array of advanced materials and specialized products. Its core chemical business includes the production and global distribution of various polyvinyl chloride (PVC) formulations, such as crosslinked, paste, and chlorinated PVC, alongside acryl grafted-vinyl chloride copolymers. The company also supplies critical additives like impact modifiers, processing aids, specialty additives, and tougheners for thermosetting resins. Furthermore, their portfolio features advanced polymers including silyl-terminated polyether, acrylic silicon, terminally reactive liquid acrylic, biodegradable polymers, and engineering resins designed for injection molding, in addition to zero birefringence materials, acrylic films, and isobutylene-based thermoplastic elastomers. Beyond chemicals, Kaneka manufactures specialized foams and films, encompassing polypropylene and Kanelite foams, extruded polystyrene insulation, polyimide films, and transparent films for optical applications. Their material science expertise extends to high thermal conductive graphite sheets, multi-layer insulation, transparent conductive films, and transparent resins engineered for exceptional heat and light resistance. In the energy and innovative products sector, Kaneka offers photovoltaic power generation systems suitable for residential, public, and industrial installations. Other cutting-edge developments include eco-friendly fur, flame-retardant materials, hair accessories, novel materials, organic EL lighting panels, and biosurfactants. Their life sciences division delivers a comprehensive range of medical and pharmaceutical offerings, which include intervention and blood purification systems, gastroenterology intervention tools, diagnostic testing equipment, regenerative medicine and cell therapy solutions, and genetic diagnostics. Additionally, they provide low molecular pharmaceutical raw materials, affinity chromatography resins for monoclonal antibody purification, biopharmaceuticals, transdermal medicines, and innovative shock-absorbing innerwear. Lastly, Kaneka is a significant player in the food and nutrition industry. Their extensive product line features dairy products, margarines, fats and oils, whipping creams, fillings, baking essentials (baker's yeast, dough improvers), processed fruits, butter, shortening, cacao butter alternatives, various creams, frozen dough, spices, and antifreeze materials. They also supply pharmaceutical and supplemental nutrition solutions, such as coenzyme Q10, lactic-acid bacteria, and functional foodstuffs, alongside agricultural fertilizers.
Führung
- Kazuhiko FujiiPresident & Representative Director
- Shinichiro KametakaExecutive Vice President & Director
- Yoshiki TakeokaManaging Executive Officer & Manager of Global Planning
- Kazuo OchiaiManaging Executive Officer
- Shinji MizusawaManaging Executive Officer
- Keiji SuzukiExecutive Officer & Accounting Department Manager
- CEO
- Kazuhiko Fujii
- Mitarbeitende
- 11.762
- Hauptsitz
- Tokyo, OS, JP
- Sektor
- Basic Materials
- Branche
- Chemicals - Specialty
- Börsengang
- 1. Jan. 2001
- Website
- kaneka.co.jp
Nachrichten
Gerade keine Nachrichten zu diesem Unternehmen.
Kurse mindestens 15 Minuten verzögert. Daten: Financial Modeling Prep. Keine Anlageberatung.